The main treatments forpost-traumatic stress disorder(PTSD) are psychologicaltherapiesand medication.
Post-Traumatic Stress Disorder Treatment Market contains market size and forecasts of Post-Traumatic Stress Disorder Treatment in Global, including the following market information:
- Global Post-Traumatic Stress Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Post-Traumatic Stress Disorder Treatment market was valued at 2479.9 million in 2021 and is projected to reach US$ 3176.2 million by 2028, at a CAGR of 3.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Post-Traumatic Stress Disorder Treatment include Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp. and Apotex, Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Post-Traumatic Stress Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Post-Traumatic Stress Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Post-Traumatic Stress Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
- Antidepressants
- Anti-Anxiety Drugs
- Others
Global Post-Traumatic Stress Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Post-Traumatic Stress Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Global Post-Traumatic Stress Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Post-Traumatic Stress Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Post-Traumatic Stress Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Post-Traumatic Stress Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer, Inc.
- GlaxoSmithKline plc
- Otsuka Pharmaceutical Co., Ltd
- Novartis AG
- AstraZeneca Plc
- Azevan Pharmaceuticals, Inc.
- Bionomics Ltd.
- Tonix Pharmaceuticals Holding Corp.
- Apotex, Inc.
Industry Market Size
